Doctiplus - We are allways here!

Mn-Sn: 8am to 9pm

Mental Health & Depression — Weekly Report — October 19, 2026

Home/Health Insights/Mental Health & Depression — October 19 – October 26, 2026
Vol. 7 · No. 47
DoctiPlus Care · Weekly Brief on Mental Health & Depression
Updated Monday · November 16, 2026
Mental Health & Depression · October 19 – October 26, 2026

Mental Health & Depression
Weekly Report

This week's data 74 new clinical trials registered across 10 countries, with 3,264 trials actively recruiting patients worldwide.
Week of October 19 – October 26, 2026
  • 74 new clinical trials registered across 10 countries.
  • 3,264 trials actively recruiting patients worldwide.
  • Notable trial: Fuzhou Aging Brain Health Initiative (3000 patients).
  • 516 new research papers published.
  • Drug safety: Most reported effect across tracked medications (sertraline, fluoxetine, escitalopram, venlafaxine, duloxetine) was Off Label Use.
  • 8 active drug recall alert(s) — see details below.

The week in numbers

Figures · October 19 – October 26, 2026
New Trials This Week
74.
registered Oct 19–Oct 26
Recruiting Now
3,264
active trials seeking patients
Countries
10
with active trials this week
Papers Published
516
new studies this week
Phase 3 Trials
0
late-stage trials this week
Fig. 01

Trials by country

Count · October 19 – October 26, 2026
United States
21
France
17
Turkey (Türkiye)
12
Not specified
8
China
8
Romania
2
United Kingdom
2
Egypt
1
Canada
1
Israel
1
0 6 12 18 21
total
Fig. 02

Trials by phase

Distribution · October 19 – October 26, 2026

New clinical trials registered this week for Mental Health & Depression. Each trial links to its full record on ClinicalTrials.gov where you can find eligibility criteria, locations, and contact information.

§ 03

This week's new registrations

Click any header to sort

74 trials registered for Mental Health & Depression. Each links to its full record on ClinicalTrials.gov.

# Trial ↓ Phase ↕ Status ↕ Enrollment ↕ Country ↕
01 Fathers and Babies (FAB) Research Study Mental Health & Depression · Northwestern University (NCT07893210) Other Recruiting 624 United States
02 Psychosocial Effects of Empathy-Based Midwifery Education on Midwifery Students and Pregnant Women Mental Health & Depression · Kahramanmaras Sutcu Imam University (NCT07889986) Other Not Yet Recruiting 224 N/A
03 Fuzhou Aging Brain Health Initiative Mental Health & Depression · Fujian Medical University Union Hospital (NCT07891429) Other Recruiting 3,000 China
04 Weighted Blankets for Dental Anxiety Mental Health & Depression · University of Pennsylvania (NCT07879846) Other Not Yet Recruiting 50 N/A
05 Chaigui Jieyu Qufa Decoction for CRF in Driver Gene-negative Lung Adenocarcinoma Trial Mental Health & Depression · Cancer Institute and Hospital, Chinese Academy of Medical Sciences (NCT07890051) Other Completed 120 China
06 Targeted Health Dialogues for Individuals With Psychosis Spectrum Disorders Mental Health & Depression · Uppsala University (NCT07888894) Other Not Yet Recruiting 60 N/A
07 Inflammatory Pathways Modulated by Prenatal Mindfulness: A Route to Improve Maternal Child Emotional Well Being and Whole Person Health Mental Health & Depression · Oregon Health and Science University (NCT07892326) Other Not Yet Recruiting 200 United States
08 REM Sleep Disruption and Its Potential Uses in Depression Management Mental Health & Depression · WAKEZ HEALTH TECH ECOSYSTEM SRL (NCT07891806) Other Completed 208 Romania
09 Buzzy Bee for Pain and Anxiety Control During Pediatric Dental Local Anesthesia Mental Health & Depression · Tanta University (NCT07886333) Other Recruiting 40 Egypt
10 Dual Neuromodulation for Depression: Boosting TMS With tES Mental Health & Depression · Mersey Care NHS Trust (NCT07879924) Other Not Yet Recruiting 60 United Kingdom
11 The Mindful Smartphone Use Study Mental Health & Depression · Brown University (NCT07892807) Other Recruiting 40 United States
12 VR During Chest Tube Removal After CABG Mental Health & Depression · Maltepe University (NCT07891299) Other Completed 82 Turkey (Türkiye)
13 Individualized Parent-Based Nutrition Education in Preschool Children With Autism Spectrum Disorder Mental Health & Depression · Firat University (NCT07884097) Other Completed 45 Turkey (Türkiye)
14 The Effect of Chewing Gum on Pain and State Anxiety During Intravenous Blood Sampling Mental Health & Depression · Dicle University (NCT07892365) Other Completed 170 Turkey (Türkiye)
15 Adapted Group Therapy Compared With Usual Care for Anxiety and Depression in Adults With an Autism Diagnosis Mental Health & Depression · Lovisenberg Diakonale Hospital (NCT07880028) Other Not Yet Recruiting 154 N/A
16 Liposomal Bupivacaine Fascia Iliaca Block for Perioperative Sleep Quality in Elderly Patients With Intertrochanteric Fracture Mental Health & Depression · Li Xiaoyuan (NCT07892859) Other Completed 80 China
17 reALIGNing Circadian Rhythm and Promoting Sleep in the Intensive Care Unit Mental Health & Depression · University of Alberta (NCT07886567) Phase 1 Not Yet Recruiting 50 Canada
18 Community-Based Intensive Treatment (CBIT): Meeting the Complex Needs of Rural Adults With Serious Mental Illness Mental Health & Depression · Yale University (NCT07887113) Other Not Yet Recruiting 25 United States
19 Effect of Intracanal Cryotherapy on Pain, Anxiety, and Salivary Irisin After Root Canal Treatment Mental Health & Depression · Alanya Alaaddin Keykubat University (NCT07889050) Other Not Yet Recruiting 130 Turkey (Türkiye)
20 Deep TMS for PTSD With Suicidal Ideation Mental Health & Depression · D.R. Rut Zaks OHAYON (NCT07880340) Other Not Yet Recruiting 72 Israel
21 Testing a Non-Deceptive Placebo Intervention for Subclinical Depressive Symptoms Mental Health & Depression · Miami University (NCT07889908) Other Not Yet Recruiting 330 United States
22 Dietary Education Intervention for Subthreshold Depression (MIND-Trial) Mental Health & Depression · Institute of Mental Health, Singapore (NCT07880652) Other Not Yet Recruiting 64 Singapore
23 Methyl Donor-Rich Diet in the Postpartum Period Mental Health & Depression · Istanbul University - Cerrahpasa (NCT07887178) Other Recruiting 100 Turkey (Türkiye)
24 A Randomized, Open-Label, 52-Week Extension Study to Evaluate the Maintenance of Remission, Relapse Prevention, and Long-Term Safety of CreNeuroS™ in Patients With Major Depressive Disorder Who Achieved Remission Following an 8-Week Parent Study Mental Health & Depression · Sichuan Credit Pharmaceutical Co., Ltd. (NCT07893002) Other Recruiting 60 India
25 The Effect of ShotBlocker on Symptoms of Pain, Anxiety, and Cortisol Hormone Levels Mental Health & Depression · Ataturk University (NCT07880496) Other Not Yet Recruiting 68 N/A
26 Rehabilitation Through Virtual Immersion & Integrated Exposure for Mild Traumatic Brain Injury (ReVIVE for mTBI) Mental Health & Depression · Johns Hopkins University (NCT07890337) Phase 1 Recruiting 30 United States
27 Breathing Meditation and VR Nature Videos in Angiography Patients: Effects on Anxiety, Comfort, and Physiology Mental Health & Depression · University of Yalova (NCT07892456) Other Recruiting 123 Turkey (Türkiye)
28 Feasibility and Acceptability of a 6-Week Myofunctional and Physical Activity Program for University Students With Excessive Daytime Sleepiness Mental Health & Depression · Kuwait University (NCT07879859) Other Completed 14 Kuwait
29 Pilot Study of a Behavioral Program for Depression in Skilled Nursing Facility Residents and Care Partners Mental Health & Depression · Massachusetts General Hospital (NCT07891546) Other Completed 14 United States
30 Anxiety and Depression in Patients With Hematologic Malignancies Mental Health & Depression · The First Affiliated Hospital of Xiamen University (NCT07883070) Other Recruiting 100 China
31 Hybrid Pilot of Personalized Parent-Child Interaction Therapy Mental Health & Depression · San Diego State University (NCT07887295) Other Not Yet Recruiting 60 United States
32 Evaluation of a Multi-Layered Digital Phenotyping, Digital Safety Plan, and Pharmacogenomic Intervention for Suicide Prevention in Adults With Depression Mental Health & Depression · Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz (NCT07885722) Other Recruiting 525 Spain
33 Effect of Alpha-Band Binaural Beats on Stress and Recovery in Third Molar Surgery Mental Health & Depression · Alperen Kalyoncu (NCT07881640) Other Recruiting 90 Turkey (Türkiye)
34 French Minds Cohort: a French Longitudinal and Multimodal Cohort of Patients With Major Mood Disorders, Psychotic Disorders, Autism Spectrum Disorders, and Healthy Controls Mental Health & Depression · Fondation FondaMental (NCT07881016) Other Recruiting 3,000 France
35 Sleep Quality and Frailty Among People Living With HIV Mental Health & Depression · National Sun Yat-sen University (NCT07880054) Other Completed 130 Taiwan
36 A Virtual Reality Program for Nursing Home Residents With Physical Disabilities Mental Health & Depression · Tung Wah College (NCT07879677) Other Not Yet Recruiting 400 N/A
37 Digital Phenotypes for Predicting Depression_Validation Mental Health & Depression · Korea University Anam Hospital (NCT07880015) Other Enrolling By Invitation 200 South Korea
38 Coping and Adaptation for Recovery From Moral Injury: A Group Intervention for Clinical Psychology Residents Mental Health & Depression · Universidad Complutense de Madrid (NCT07887581) Other Not Yet Recruiting 10 N/A
39 Dental Anxiety in Children Attending Emergency Versus Routine Dental Care Mental Health & Depression · Marmara University (NCT07882914) Other Completed 47 Turkey (Türkiye)
40 Effects of Manual Acupuncture on Malondialdehyde Levels and State Anxiety Inventory Scores in Active Smokers: A Randomized Controlled Clinical Trial Mental Health & Depression · Universitas Indonesia (NCT07888803) Other Not Yet Recruiting 44 Indonesia
41 Effects of Connective Tissue Massage Plus Biofeedback for Dyssynergic Defecation Mental Health & Depression · Selcuk University (NCT07890727) Other Recruiting 56 Turkey (Türkiye)
42 Virtual Reality for Pain and Anxiety During Intravenous Catheterization Mental Health & Depression · Erzincan Binali Yildirim Universitesi (NCT07884682) Other Completed 136 Turkey (Türkiye)
43 Reflexology Hand Massage After Cesarean Section Mental Health & Depression · Dokuz Eylul University (NCT07880587) Other Recruiting 40 Turkey (Türkiye)
44 Tai Chi Training for Persons With Multiple Sclerosis. Mental Health & Depression · Karolinska Institutet (NCT07890974) Other Active Not Recruiting 35 Sweden
45 Effects of Daily Avocado Consumption on Sleep and Skin Health in Postmenopausal Females Mental Health & Depression · San Diego State University (NCT07880444) Other Not Yet Recruiting 74 N/A
46 Trauma Suppression Training for Veterans Mental Health & Depression · Palo Alto Veterans Institute for Research (NCT07891559) Other Completed 11 United States
47 Sensation Seeking and TMS Response in TRD Mental Health & Depression · Technical University of Munich (NCT07889739) Other Recruiting 100 Germany
48 Physical Activity, Sleep Quality, and Respiratory Function in Obstructive Sleep Apnea Mental Health & Depression · Medipol University (NCT07889154) Other Not Yet Recruiting 48 Turkey (Türkiye)
49 Postpartum Care in the NICU Multi-Site Breastfeeding Mental Health & Depression · Children's Hospital of Philadelphia (NCT07881731) Other Not Yet Recruiting 640 United States
50 Temporal Interference Stimulation in Major Depressive Disorder: A Pilot Feasibility Study Mental Health & Depression · Ruijin Hospital (NCT07888387) Other Completed 15 China
§ 04

Adverse event reports

FDA FAERS · 2025 data

Adverse drug event reports compiled from the FDA's FAERS database for medications commonly prescribed for Mental Health & Depression. These reports reflect what patients and healthcare providers have reported — they do not confirm a drug caused the effect.

Reports by drug

DrugTop effectCount
sertraline Nausea 958
fluoxetine Off Label Use 508
escitalopram Fatigue 725
venlafaxine Off Label Use 734
duloxetine Off Label Use 667

Recalls & safety notices

§ 05 · 8 items this week

FDA drug recall notices for medications related to Mental Health & Depression. If your medication is listed, contact your pharmacist or visit fda.gov/safety/recalls for guidance. No recall listed does not guarantee safety — always consult your healthcare provider.

IIClass

DULOXETINE HYDROCHLORIDE

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above safety assessment limit

ManufacturerBreckenridge Pharmaceutical, Inc. DistributionU.S Nationwide StatusOngoing
Jul 15
2025
IIClass

DULOXETINE HYDROCHLORIDE

CGMP Deviations: presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.

ManufacturerBreckenridge Pharmaceutical, Inc DistributionNationwide in the US StatusOngoing
Dec 6
2024
IIClass

DULOXETINE HYDROCHLORIDE

CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit

ManufacturerBreckenridge Pharmaceutical, Inc. DistributionNationwide within the United States StatusOngoing
Nov 24
2025
IIClass

DULOXETINE HYDROCHLORIDE

CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.

ManufacturerBreckenridge Pharmaceutical, Inc DistributionUS Nationwide. StatusOngoing
Apr 14
2025
IIClass

DULOXETINE HYDROCHLORIDE

CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.

ManufacturerBreckenridge Pharmaceutical, Inc DistributionUS Nationwide. StatusOngoing
Apr 14
2025
IIClass

DULOXETINE HYDROCHLORIDE

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.

ManufacturerBreckenridge Pharmaceutical, Inc. DistributionNJ, AZ, IN StatusOngoing
Jul 25
2025
IIClass

DULOXETINE

CGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA recommended limit of 0.83 ppm, identified at the 12-month and 18-month long-term stability intervals.

ManufacturerAjanta Pharma Ltd. DistributionNationwide within U.S StatusOngoing
Apr 29
2026
IIClass

DULOXETINE HYDROCHLORIDE

CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit

ManufacturerBreckenridge Pharmaceutical, Inc. DistributionNationwide within the United States StatusOngoing
Nov 24
2025
§ 06

Published research

516 papers

Recently published peer-reviewed studies related to Mental Health & Depression, sourced from PubMed and Semantic Scholar. Click any title to read the full paper, or expand the abstract for a quick summary.

# Study Journal Date Source
01 Non-invasive skin trace elementomics reveals a characteristic pattern of essential element deficiency and toxic element accumulation in children with ADHD. Lei Y et al. 10.1007/s10534-026-00901-y
View abstract

Attention-deficit/hyperactivity disorder (ADHD) is the most common neurodevelopmental disorder in childhood. Its clinical diagnosis primarily relies on behavioral assessments, lacking objective and non-invasive biological indicators. Trace elements are involved in neurotransmitter synthesis, myelin development, and prefrontal cortex function regulation, and their imbalance may be associated with the pathogenesis of ADHD. However, previous studies have mostly focused on single elements, lacking systematic evidence at the omics level. To analyze the differences in 30 skin element levels between children with ADHD and healthy controls, and to explore the associations of elemental imbalances with core symptoms, anxiety, and executive function, thereby providing a basis for non-invasive screening of childhood ADHD. A total of 549 children with ADHD and 963 healthy controls were enrolled. Skin element levels were measured using a non-invasive high-throughput technique. Behavioral assessments were performed using the CONNERS, SNAP‑IV, SCARED, and WEISS scales. Analysis of covariance (ANCOVA) with age as a covariate was used to compare intergroup differences in element levels. Partial correlation analysis was applied to control for age as a confounding factor. The Benjamini‑Hochberg method was used to control the false discovery rate (FDR) for multiple comparison correction, with a significance threshold of q < 0.05. After adjusting for age and FDR correction, 28 elements showed significant differences between the ADHD group and the control group. In the ADHD group, essential/potentially beneficial elements such as Mg, Zn, I, Cr, Li and Ge were decreased, whereas B and harmful elements including Pb, Hg, Cd, As, Al, Be, and Ba were increased. Multiple elements exhibited stable associations with inattention, hyperactivity-impulsivity, anxiety, and risk-taking behavior. Children with ADHD displayed a complex network pattern of synergistic and antagonistic inter-element relationships. Children with ADHD exhibit a characteristic skin trace elementomic imbalance, characterized by decreased beneficial elements and increased harmful elements, which is closely associated with behavioral symptoms. Non-invasive skin elementomics may serve as a reference indicator for population-based risk screening of childhood ADHD and holds promise for population-based screening.

Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine 2026 Oct 25 PubMed
02 The role of hope and its association with quality of life in individuals with chronic pain - insights from a daily diary study. Joo J et al. 10.1007/s11136-026-04413-7
View abstract

PURPOSE: Hope has been identified as a beneficial factor for enhancing quality of life (QoL), particularly for individuals with chronic disease, including chronic pain. However, significant gaps remain in understanding how hope and QoL intersect and relate to one another. The current study investigated whether daily hope frequency, defined as how often participants felt hopeful each day, can predict next-day QoL among individuals with chronic pain who are using cannabis and opioids to manage pain. METHODS: This was an observational study, approved by the Institutional Review Board of the Johns Hopkins Bloomberg School of Public Health (Protocol: IRB00009327). Participants (N = 132) using opioids and cannabis for chronic pain completed a baseline survey and 30-day daily diaries assessing hope frequency, QoL, and sleep satisfaction. Participants (mean age = 42.7, SD = 13.9) were predominantly male (58.3%) and Non-Hispanic White (63.6%). Linear mixed-effects models were used to test the lagged effects of daily hope frequency, decomposed into between- and within-person components, on next-day QoL, controlling for baseline variables, daily sleep satisfaction, and previous-day QoL. Intraindividual variabilities were also examined. RESULTS: Higher hope frequency was significantly associated with greater next-day QoL both between participants (i.e., participants with higher average hope reported higher QoL) and within participants (i.e., on days when hope was higher than a participant's own average), even after controlling for previous-day QoL and sleep satisfaction. While higher baseline hope and QoL scores were associated with higher average QoL over the 30-day period, intraindividual variability in hope was not significantly associated with QoL. CONCLUSIONS: Our daily diary study found that previous-day hope frequency - both stable individual differences and day-to-day fluctuations - was associated with next-day QoL in individuals with chronic pain who were co-using cannabis and opioids.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2026 Oct 25 PubMed
03 A mechanistic PK/PD model of fentanyl overdose and intranasal naloxone rescue incorporating receptor-level competition. Hossain JA et al. 10.1007/s10928-026-10070-7
View abstract

To develop and evaluate a PK/PD model that mechanistically describes the competitive interaction between intravenous (IV) fentanyl and intranasal (IN) naloxone at brain μ-opioid receptors (MORs) and simulates reversal of respiratory depression. A compartmental PK/PD model incorporating central, peripheral, brain and nasal compartments was parameterized sequentially using human plasma concentration, PET MOR-occupancy, and controlled isohypercapnic ventilation data, supplemented by literature-derived constraints where direct estimation was not supported. Fentanyl-MOR binding and release were modeled kinetically, whereas naloxone binding was represented by a rapid-equilibrium relationship. A 1,000-member virtual ensemble was used to propagate parameter uncertainty, and Sobol global sensitivity analysis evaluated determinants of ventilation recovery. The model reproduced the component clinical datasets used for calibration and simulated rapid ventilation recovery after IN naloxone. Simulations indicated that the apparent nasal-to-brain pathway was an important contributor to early rescue, whereas the systemic pathway contributed minimally during the first minutes after dosing. In nominal simulations, recovery began when the free brain naloxone:fentanyl molar concentration ratio reached approximately 0.063. Sobol analysis showed that fentanyl MOR affinity and brain disposition dominated very early recovery, while naloxone MOR affinity and apparent nasal-to-brain allocation became increasingly influential over the subsequent 10-15 minutes. This PK/PD framework links drug disposition, receptor competition and ventilation response in a unified model. It provides a mechanistic platform for evaluating naloxone dose, repeat-dosing, and formulation strategies while explicitly accounting for parameter uncertainty and the limitations of controlled isohypercapnic calibration data.

Journal of pharmacokinetics and pharmacodynamics 2026 Oct 25 PubMed
04 Efficacy, time-course, and adverse events of antidepressants in pediatric social anxiety disorder: a systematic review and meta-analysis of randomized controlled trials. Ohi K et al. 10.1007/s00787-026-03236-8
View abstract

Antidepressants are established as effective treatments for social anxiety disorder (SAD) in adults and for anxiety disorders in children and adolescents. However, evidence specific to pediatric SAD remains limited, and disorder-specific effects, the time course of social anxiety (SA) symptom improvement, and adverse event (AE) profiles have not been systematically evaluated. We conducted a meta-analysis of randomized controlled trials (RCTs) to investigate the efficacy, time course, and AEs of antidepressants in children and adolescents with SAD. A systematic search of PubMed and CENTRAL identified RCTs comparing antidepressants with placebo in participants younger than 18 years with SAD. Between-group differences in treatment response at the final assessment point were evaluated using the Clinical Global Impressions-Improvement (CGI-I ≤ 2). Continuous outcomes of SA symptoms were extracted at each time point and analyzed using standardized mean differences to assess changes over time. Time-course effects were examined to characterize the trajectory of symptom improvement using mixed-effects meta-regression and linear mixed-effects models. Between-group differences in AEs were evaluated using pooled risk differences (RDs). Three RCTs including 669 participants were included. Antidepressants were associated with a higher likelihood of response compared with placebo (odds ratio = 4.05, p = 7.52 × 10). Longitudinal analyses demonstrated that improvements in SA symptoms increased over time (p = 1.15 × 10), with effect sizes reaching approximately - 0.7 at later time points, following a nonlinear trajectory with diminishing gains after approximately 8-12 weeks. Antidepressants were associated with increased risks of several AEs, including nausea/vomiting (RD = 0.071; 7.1%, p = 0.025), asthenia (RD = 0.086; 8.6%, p = 1.37 × 10), and suicidal ideation (RD = 0.023; 2.3%, p = 7.59 × 10), whereas no increase was observed in other assessed AEs, including self-harm behavior or suicide attempts. These findings suggest the potential efficacy of antidepressants in pediatric SAD, with treatment gains slowing after 8-12 weeks, while the available data did not indicate an increase in self-harm behavior or suicide attempts.

European child & adolescent psychiatry 2026 Oct 25 PubMed
05 Olfactory Training and Patient-Centered Outcomes Beyond Smell: A Systematic Review and Meta-Analysis. Kim JS et al. 10.1002/alr.70290
View abstract

BACKGROUND: Olfactory dysfunction (OD) is associated with diminished quality of life (QOL), depressive symptoms, and cognitive decline, and emerging evidence suggests that olfactory training (OT) may mitigate both OD and its broader impacts. This review aims to systematically evaluate the effects of OT on QOL, depression, and cognitive outcomes. METHODS: PubMed, Embase, Cochrane, Scopus, and Web of Science were searched for studies published between 1990 and 2025. PRISMA guidelines were followed for study screening and data extraction. Studies evaluating the effects of OT on QOL, depressive symptoms, or cognitive function were included. Random-effects models were used to pool within-group standardized mean changes (SMC) and between-group standardized mean differences (SMD). RESULTS: Fifty-one studies met inclusion criteria, with 19 included in quantitative synthesis. OT was associated with improvement in olfactory-specific QOL (Questionnaire of Olfactory Disorders [QOD] SMC = 1.29; 95% CI [0.04-2.55]). Among controlled trials, OT produced a significant advantage in QOD improvement over no-OT (QOD SMD = 0.40; 95% CI: 0.04-0.76). OT was associated with a modest improvement in global cognitive performance (Montreal Cognitive Assessment mean difference = 0.65; 95% CI [0.35, 0.94]), but no significant effect was observed on depressive symptoms (Beck Depression Inventory SMC = -0.20; 95% CI: [-0.55, 0.14]). CONCLUSIONS: OT is associated with improved olfactory-specific QOL and cognitive benefits. These findings support the potential of OT as a low-cost intervention to support the multifaceted challenges experienced by individuals with OD, while highlighting the need for adequately powered studies to clarify its effectiveness for treating OD-associated depression.

International forum of allergy & rhinology 2026 Oct 25 PubMed
06 The association between pension and mental health of older adults: Evidence from China. Guo X et al. 10.1177/13591053261493331
View abstract

In the context of high coverage of social pension insurance in China, there is a lack of comprehensive empirical research on how different pension levels affect the mental health of older individuals. Drawing on nationally representative data from the 2018 China Health and Retirement Longitudinal Study, this study empirically examines the link between pension and the mental health of older adults in China. Furthermore, a three-step approach and Karlson-Holm-Breen decomposition method were employed to estimate the mediating effect of social activities. The results indicate that pension level is related to older adults' mental health. Further analysis demonstrates that pensions mitigate depressive symptoms among older Chinese adults through increased participation in social activities. The positive association between pension and mental health is more pronounced among older adults without wage income. Our study provides evidence for China's efforts to refine the social pension insurance system and gradually enhance pension benefits.

Journal of health psychology 2026 Oct 25 PubMed
07 The Effect of Mindfulness-Based Cognitive Therapy on Kinesiophobia in Older Adults with Chronic Knee Osteoarthritis: A Randomized Controlled Trial. Kheirkhah Z et al. 10.2147/CIA.S638393
View abstract

PURPOSE: To determine the effect of mindfulness-based cognitive therapy on kinesiophobia in older adults with chronic knee osteoarthritis. PATIENTS AND METHODS: This randomized clinical trial conducted among 56 older patients with knee osteoarthritis at health centers in Kashan, Iran, in 2024. Participants were selected via consecutive sampling and randomly assigned to either an intervention (n = 28) or a control (n = 28) group using block randomization. The intervention group participated in eight 90 minute sessions of Mindfulness Based Cognitive Therapy, while the control group received routine care. Kinesiophobia was measured with the Tampa Scale for Kinesiophobia (TSK11) at baseline, week 4 (immediately post intervention), and week 8 (four week follow up). Covariate adjusted repeated measures ANCOVA was performed, adjusting for age, number of children, and baseline pain intensity. Statistical significance was set at p < 0.05. All participants completed follow up. RESULTS: The mean kinesiophobia score decreased from 29.46 ± 3.81 at baseline to 25.68 ± 3.22 at week 8 in the intervention group and from 28.64 ± 4.78 to 26.68 ± 5.15 in the control group. The adjusted repeated-measures analysis showed a significant group-by-time interaction (Wilks' Λ = 0.88, F(2.50) = 3.34, p = 0.040, ηp = 0.11), indicating different trajectories of change between groups. However, adjusted between-group differences were not statistically significant at baseline, week 4, or week 8 (all p > 0.05). The adjusted difference in change from baseline to week 8 was -1.60 points (95% CI -3.25 to 0.05; p = 0.05). Within-group Bonferroni-adjusted comparisons showed significant reductions across all time intervals in the intervention group (all p < 0.001) and from baseline to week 4 and week 8 in the control group (p = 0.0022 and p = 0.0028, respectively), but not between weeks 4 and 8 (p = 0.13). CONCLUSION: Four weeks of MBCT may influence the trajectory of kinesiophobia over time in older adults with knee osteoarthritis. TRIAL REGISTRATION: Registered in the Iranian Registry of Clinical Trials (IRCT20231105059961N1).

Clinical interventions in aging 2026 PubMed
08 Sustained Viral Suppression and its association with Psychiatric Morbidity and Sleep Quality among Older Adults with Human Immunodeficiency Virus: Evidence from a Retrospective Cohort in Ibadan, Nigeria. Elugbadebo OO et al. 10.64898/2026.10.07.26364957
View abstract

UNLABELLED: Purpose Older adults with HIV are at risk of psychiatric disorders and poor sleep quality, but evidence from sub-Saharan Africa is limited, particularly regarding sustained viral suppression. This study examined the prevalence of psychiatric disorders and poor sleep quality symptoms and their association with sustained viral suppression among older adults with HIV in Nigeria. METHODS: A retrospective cohort study was conducted among older adults receiving care at a tertiary HIV clinic in Ibadan, Nigeria. Viral load data from 2019-2023 were abstracted from medical records to determine sustained viral load suppression, while psychiatric morbidity and sleep quality were assessed cross-sectionally in 2023. Psychiatric assessments included major depressive disorder, anxiety disorder, bipolar disorder and mania. Mixed-effects logistic regression assessed changes in viral suppression over time and associations with psychiatric morbidity and sleep quality. RESULTS: Among 400 participants, 63.5% were female and mean age was 58.2 years (S.D 6.5). A total of 25.8% had major depressive disorder, 17.5% had anxiety disorder, 29.3% had poor sleep quality, 3.3%, bipolar disorder, and 1.0% mania. Viral suppression improved significantly over the retrospective period. Sustained viral suppression was significantly associated with higher odds of good sleep quality (OR = 1.69, 95% CI: 1.07 to 2.66, p = 0.025), but not psychiatric morbidity. CONCLUSION: Psychiatric disorders and poor sleep quality are common among older adults with HIV in Nigeria. Sustained viral suppression was associated with better sleep quality but not psychiatric morbidity highlighting the importance of integrating mental health and sleep assessment into comprehensive HIV care for older adults.

medRxiv : the preprint server for health sciences 2026 Oct 20 PubMed
09 Substance use disorder, psychiatric illness, and suicide risk among hospitalized incarcerated adults: A retrospective study using National Inpatient Sample (NIS) database. Shrestha K et al. 10.1111/ajad.70217
View abstract

BACKGROUND AND OBJECTIVES: Hospitalization offers a limited but important opportunity to address medical and psychiatric needs among incarcerated adults, who have high burdens of substance use disorder (SUD), mental illness, and suicide-related risk. National comparative data by SUD status remain sparse. METHODS: We conducted a retrospective study using the National Inpatient Sample (2016-2021) of hospitalized adults with ICD-10 codes indicating incarceration to evaluate the association between SUD and psychiatric comorbidity, suicidality, and hospitalization outcomes in the United States. RESULTS: Among 92,715 (N) hospitalized incarcerated adults, 40.4% had SUD. Patients with SUD were younger (40.7 ± 11.4 vs. 48.4 ± 13.9 years) and more frequently female (22.2% vs. 12.6%). SUD was strongly associated with suicidal ideation (75.4% vs. 38.6%; adjusted odds ratio [aOR] 3.73; p < .001). Multivariable analyses demonstrated higher odds of major depressive disorder (aOR 1.43), schizophrenia-spectrum disorders (aOR 1.61), bipolar disorder (aOR 1.66), anxiety disorders (aOR 2.07), trauma-related disorders (aOR 1.90), and personality disorders (aOR 1.63) (all p < .001). Despite this, SUD was associated with lower in-hospital mortality and total charges, with no significant difference in length of stay. DISCUSSION AND CONCLUSIONS: SUD is highly prevalent and independently associated with increased psychiatric burden and suicide-related risk in hospitalized incarcerated adults. These findings support prioritizing integrated inpatient approaches to address co-occurring addiction and mental health conditions in this vulnerable population. SCIENTIFIC SIGNIFICANCE: These findings identify SUD as a significant factor associated with psychiatric morbidity and suicidality among incarcerated patients, highlighting hospitalization as an important opportunity for integrated screening, assessment, and care delivery.

The American journal on addictions 2026 Oct 24 PubMed
10 Noise, Inequality, and Mental Health. Urban Challenges in the State of Mexico. Martínez-Martínez OA et al. 10.1007/s11524-026-01176-x
View abstract

Environmental noise is an increasing public health concern, with effects that extend beyond hearing loss to include anxiety and depression. In the Global South, however, evidence remains limited, and most studies focus primarily on objective exposure measures, while subjective dimensions of noise experience remain less explored. This study examines the relationship between sociodemographic characteristics, perceived noise, and mental health in households of the State of Mexico, considering urban-rural differences. Data were collected from a probabilistic, stratified household survey (n = 400). Structural equation modeling (SEM) was applied using the diagonally weighted least squares estimator adjusted with expansion factors, and an exploratory spatial analysis was conducted through IDW interpolation to explore territorial patterns in predicted outcomes. The findings indicate that household size was a significant predictor of perceived noise, with larger households reporting higher levels. Perceived noise was significantly associated with depressive symptoms but not with anxiety, and living in urban municipalities was directly associated with higher levels of depression, independent of perceived noise. Spatial analysis further revealed that patterns of high perceived noise and depression are concentrated in metropolitan areas. Overall, the results suggest that environmental noise is a relevant, though modest, environmental factor associated with mental health in the State of Mexico, particularly in urban contexts, indicating that it merits consideration alongside other urban stressors in planning and public health efforts addressing territorial disparities.

Journal of urban health : bulletin of the New York Academy of Medicine 2026 Oct 24 PubMed
11 Unequal Burdens of Health Misinformation: Disparities in Exposure, Susceptibility, and Outcomes. Tsichlis JT et al. 10.1007/s40615-026-03163-z
View abstract

Health misinformation is a pervasive and inequitable public health challenge with consequences that extend beyond knowledge deficits to influence behavior, healthcare engagement, and psychosocial well-being. This narrative review and critical synthesis examines current evidence on health misinformation disparities, drawing on empirical, theoretical, and policy-relevant literature to characterize differential patterns of exposure, susceptibility, and outcomes across population groups. Exposure and susceptibility are not evenly distributed, as they disproportionately affect populations with intersecting vulnerabilities related to race, ethnicity, socioeconomic status, language, digital access, and health literacy. Evidence demonstrates that susceptibility is shaped by historical and structural factors including medical mistrust, limited health and digital literacy, and algorithmically reinforced social media ecosystems. Meanwhile, age, cognitive style, and sociocultural context further modulate risk. Health misinformation has tangible downstream effects, contributing to vaccine hesitancy, delayed or avoided care, and adverse psychosocial outcomes, including increased anxiety, depressive symptoms, and erosion of trust in healthcare institutions. Cross-national data indicate that disparities are amplified in regions with weaker digital health infrastructure and limited access to timely, multilingual information. Interventions such as debunking, prebunking, media literacy programs, and community-engaged initiatives show the strongest evidence for correcting specific false beliefs whereas evidence for durable translation to behavioral change and sustained health outcomes is more limited and requires further evaluation in equity-diverse populations. Addressing health misinformation through an equity-focused lens is critical for mitigating disparities, restoring institutional trust, and promoting equitable health outcomes across populations.

Journal of racial and ethnic health disparities 2026 Oct 24 PubMed
12 Perceived problems in movement control at the piano among Japanese conservatory-trained classical pianists: a cross-sectional questionnaire survey screening for musician's dystonia. Satoh H et al. 10.1007/s00702-026-03313-x
View abstract

Musician's dystonia is a devastating task-specific movement disorder that robs performers of voluntary motor control during playing and, in progressive cases, extends to daily life, severely impacting mental health and career continuity. While research on musician's dystonia is extensive, studies specifically targeting professionally trained pianists are limited, and its etiology and optimal treatment remain unclear. This study investigated the characteristics and risk factors of focal dystonia among pianists who have received specialized piano training. An anonymous questionnaire was distributed to 2,863 individuals, including members of a professional musicians' association in Japan (Japan Federation of Musicians), as well as students, piano teachers, and performers at music universities. Individuals reporting involuntary finger or wrist movements occurring exclusively during piano performance were operationally classified as suspected dystonia, a self-reported category that does not constitute a clinical diagnosis, and underwent secondary screening. Comparative statistical analysis was performed between the suspected dystonia group and a non-dystonia group. Among 241 valid respondents, 28 (11.6%) met this criterion. Longer daily practice time and overseas study experience were significantly more frequent in this group. The fourth and fifth fingers of the right hand were most affected. Eight of these 28 respondents (28.6%) reported symptoms extending beyond piano playing into daily life. This study suggests that prolonged practice, changes in teaching methodology, and non-physiological movement patterns warrant further investigation as potential contributing factors. It emphasizes the necessity for prevention strategies and treatment frameworks tailored specifically to pianists.

Journal of neural transmission (Vienna, Austria : 1996) 2026 Oct 24 PubMed
13 Reliability and analytical validity of the MX3 hydration testing system during exercise in the heat. Zhao X et al. 10.1007/s00421-026-06476-3
View abstract

PURPOSE: The MX3 Hydration Testing System provides portable saliva osmolality (SOsm) measurements, but its between-day reliability and analytical validity against a laboratory reference osmometer remain unclear. This study evaluated MX3 reliability and analytical validity and examined whether measurement performance differed between direct tongue and collected-saliva sampling approaches. METHODS: Twenty healthy, physically active adults (10 females) completed one 30-min familiarization trial and two 120-min self-paced exercise trials in the heat. SOsm was measured using MX3 directly from the tongue and from collected saliva samples and compared with a laboratory freezing-point depression osmometer (OSMO1). Between-day reliability was evaluated using the coefficient of variation (CV), intraclass correlation coefficient (ICC), and Bland-Altman analysis. Analytical validity was assessed using linear regression, CV, and Bland-Altman analysis. RESULTS: Direct tongue measurements demonstrated poor between-day reliability (CV = 31-35%; ICC = - 0.003-0.053), whereas collected-saliva measurements demonstrated lower variability and moderate reliability (CV = 17-18%; ICC = 0.618-0.663). Collected-saliva measurements were strongly related to OSMO1 across all measurement conditions (R = 0.570-0.821; all p < 0.001), with mean biases ranging from - 23.9 to - 25.9 mOsm/kg and 95% limits of agreement (LoA) ranging from - 75.4 to 27.1 mOsm/kg. In contrast, direct tongue measurements showed weaker and less consistent relationships with OSMO1 (R = 0.001-0.282; p = 0.005-0.804), greater variability (CV = 36-51%), and larger negative biases (- 31.3 to - 52.0 mOsm/kg), with 95% LoA ranging from - 134.4 to 30.4 mOsm/kg. Agreement between the two MX3 sampling approaches was limited, particularly following exercise. CONCLUSION: Collected-saliva MX3 measurements demonstrated better between-day reliability and analytical performance than direct tongue measurements, although systematic disagreement with the reference osmometer remained. MX3 measurement performance differed between saliva sampling approaches, supporting further validation of the collected-saliva approach.

European journal of applied physiology 2026 Oct 24 PubMed
14 Comorbidity management in inflammatory rheumatic diseases: a dual-perspective survey of patients and rheumatologists. Bartsch V et al. 10.1186/s13075-026-03924-5
View abstract

BACKGROUND: Comorbidities are major contributors to morbidity and mortality in patients with inflammatory rheumatic diseases (IRDs). We assessed real-world implementation of European Alliance of Associations for Rheumatology (EULAR) points to consider for comorbidity management and perceptions of responsibility. METHODS: We conducted a cross-sectional anonymous online survey among patients with IRDs and rheumatologists in Germany. Two questionnaires assessed demographics, perceived responsibility for comorbidity management, and implementation of preventive measures across five domains: cardiovascular risk, infections, malignancies, depression, and osteoporosis. Responses were analysed using descriptive statistics and group comparisons (chi-square, Fisher's exact, Mann-Whitney U tests). RESULTS: A total of 2,213 patients with IRDs and 140 rheumatologists participated. Patient-reported implementation of comorbidity management in routine care was low across all domains (mean 28.8%). Rheumatologists reported substantially higher implementation than patients across all domains, including blood pressure monitoring (83.6% vs 33.8%) and vaccination checks (77.9% vs 33.2%). Most rheumatologists (69.3%) reported that no structured comorbidity screening was in place. Reported barriers included lack of time (91.4%), unclear responsibilities (48.6%), staff shortages (40.0%), and lack of reimbursement (35.0%). Rheumatologists favoured shared responsibility with general practitioners (GPs) for documentation (61.4%) and screening (48.6%), whereas treatment was more often assigned to GPs alone (60.7%). Patients more frequently assigned primary responsibility to GPs, particularly for cardiovascular risk management (72.6%) and vaccinations (73.8%). CONCLUSIONS: Comorbidity management in IRDs is poorly implemented in routine care, and perceptions of responsibility differ between patients and rheumatologists. Clearer role definitions, stronger guidance from rheumatology organisations, and practical tools are needed to improve implementation.

Arthritis research & therapy 2026 Oct 23 PubMed
15 Association of pain intensity and pain extent as assessed by pain drawings with clinical and psychosocial factors in patients with temporomandibular disorders. Arefeh E et al. 10.1016/j.prosdent.2026.09.011
View abstract

STATEMENT OF PROBLEM: Despite the widespread use of pain drawings in the assessment of temporomandibular disorders (TMDs), clinicians still lack clear evidence for which pain dimensions derived from these tools meaningfully reflect functional disability and psychosocial burden. PURPOSE: The purpose of this cross-sectional clinical study was to investigate the relationship between the intensity and extent of pain and various clinical and psychosocial factors in Iranian patients with TMDs. MATERIAL AND METHODS: Patients diagnosed with TMDs according to the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) were recruited from a clinical population. Pain extent was quantified using standardized head and neck pain drawings, while pain intensity was assessed using the Characteristic Pain Intensity (CPI) derived from the Graded Chronic Pain Scale (GCPS). Clinical and psychosocial variables were evaluated using validated questionnaires, including pain-related disability (GCPS), jaw functional limitation (JFLS-8), depression (PHQ-9), anxiety (GAD-7), psychological distress (PHQ-4), somatic symptom burden (PHQ-15), and oral parafunctional behaviors (OBC). Data were analyzed using the Spearman rho, and group comparisons were performed using independent t tests (α=.05). RESULTS: A total of 114 participants aged 18 to 65 years were included. CPI (GCPS) showed a significant positive association with pain-related disability (P=.008), indicating greater functional impairment with increasing CPI (GCPS). In contrast, pain extent was not significantly associated with pain-related disability, jaw functional limitation, or any psychosocial variables (P>.05 for all). No significant differences in CPI (GCPS) or pain extent were observed according to sex (P=.546 and P=.261, respectively) or pain laterality (P=.108 and P=.249, respectively). CONCLUSIONS: CPI (GCPS) appeared to be a more clinically meaningful indicator of functional impact than the spatial extent of pain distribution as assessed by head and neck pain drawings in patients with TMDs. Pain drawings should be interpreted as a complementary descriptive tool rather than a standalone marker of disease severity or psychosocial burden, with greater emphasis placed on CPI (GCPS) in clinical assessment.

The Journal of prosthetic dentistry 2026 Oct 24 PubMed
16 Longitudinal Recovery Trajectories of Instrumental Activities of Daily Living and Social Participation after Hematopoietic Stem Cell Transplantation: A Prospective Study. Asai K et al. 10.1016/j.jtct.2026.10.039
View abstract

BACKGROUND: As survival after hematopoietic stem cell transplantation (HSCT) continues to improve, supporting long-term functional recovery and successful community reintegration has become a key clinical priority. Prior survivorship research has largely emphasized physiological outcomes, including muscle strength and exercise tolerance, or global health-related quality of life (QOL). Nonetheless, these measures may not fully capture survivors' ability to manage complex daily activities or resume meaningful social roles in real-world settings. OBJECTIVE: This study aimed to investigate the longitudinal trajectories of instrumental activities of daily living (IADL) and social participation during the 48 weeks after discharge in patients undergoing HSCT. We also explored potential differences in these trajectories by transplant type. STUDY DESIGN: This prospective observational study enrolled 61 patients undergoing HSCT, including 37 allogeneic recipients (median age, 56.0 years; 25/37 [67.6%] male) and 24 autologous recipients (median age, 63.0 years; 18/24 [75.0%] male). The primary outcome was IADL and social participation measured using the Frenchay Activities Index (FAI). Secondary outcomes included anxiety and depression symptoms, assessed using the Hospital Anxiety and Depression Scale; fatigue, assessed using the Cancer Fatigue Scale (CFS); and quality of life, measured using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30). Longitudinal changes were analyzed using linear mixed-effects models. RESULTS: A significant main effect of time was observed for FAI scores (p < 0.001), whereas transplant type (p = 0.443) and the time × transplant type interaction (p = 0.342) were not significant. In the allogeneic group, FAI scores decreased from 19.0 (13.0-28.0) at baseline to 13.0 (10.0-20.0) at 4 weeks after discharge, then improved to 26.0 (21.0-29.0) at 48 weeks. In the autologous group, FAI scores exhibited more modest changes over time, from 19.5 (8.8-24.5) at baseline to 16.0 (8.0-23.0) at 4 weeks and 19.5 (15.8-30.5) at 48 weeks. Post hoc analyses demonstrated that FAI scores at 12, 24, and 48 weeks were significantly higher than those at 4 weeks (p < 0.01). For the secondary outcomes, QOL (EORTC QLQ-C30) also showed significant improvement over time, whereas fatigue (CFS) showed no comparable improvement over time. CONCLUSION: IADL and social participation declined early after discharge and subsequently improved over 48 weeks after HSCT. Recovery trajectories appeared broadly similar between allogeneic and autologous recipients; however, the modest sample size and attrition over follow-up limit conclusions regarding transplant-type differences. Repeated assessment may help identify delayed functional recovery and inform survivorship care and rehabilitation planning. These findings should be confirmed in larger multicenter studies.

Transplantation and cellular therapy 2026 Oct 24 PubMed
17 EFFICACY OF EUGENOL AGAINST N, N'-DIMETHYL-4,4'-BIPYRIDINIUM DICHLORIDE (PARAQUAT)-INDUCED NA⁺/K⁺/CA²⁺ DYSREGULATION AND BEHAVIORAL DEFICITS IN RAT MODELS. Obinna UO et al. 10.1016/j.brainresbull.2026.112176
View abstract

BACKGROUND: Ion level disruption causes mitochondrial aberration and alters cytochrome c activity. PURPOSE: To evaluate the efficacy of eugenol in Na+/K+/Ca2+ Cytochrome C dysregulation and behavioral deficits in Wistar rats. METHODS: Forty male Wistar rats were acclimatised for two weeks and assigned to five groups of 8 rats. Group A received feed and normal saline. Groups B, C, D, and E received 10mg/kg paraquat (PQ), and then C, D, and E received eugenol at graded doses of 200, 400, and 600mg/kg. PQ was administered for 28 days at 1-day intervals, before the rats were treated with eugenol for 14 days via the oral route. Social interaction and depression-like behaviours were studied using a sociability chamber and a tail suspension box. RESULTS: In Group B, interstitial Na+/K+ increased, while Ca2+ significantly decreased. In the treated groups, Na+/K+ and Ca2+ levels decreased and increased significantly, respectively. Cytochrome C, Caspase cleavage, and Full-length cytokeratin-18 were significantly increased in the untreated Group B and were reduced by eugenol (p<0.05). In the PQ-untreated Group, social interaction and immobility were impaired, but eugenol attenuated these behavioral deficits. Dopamine levels and gamma-glutamyl transferase activities were lowered and increased in Group B, respectively, while eugenol increased and reduced them (p<0.05). Microscopically, paraquat caused a significant loss of dopaminergic neurons, formation of Lewy bodies, and Pyknosis in the substantia nigra. CONCLUSIONS: Overall, eugenol shows valuable therapeutic potential against pesticide-induced neurotoxicity and associated ion dysregulation.

Brain research bulletin 2026 Oct 24 PubMed
18 From Cell to Circuit: Altered Functional Network Topology in iPSC-derived Neuronal Circuits in Major Depressive Disorder. Issa R et al. 10.1016/j.neuroimage.2026.122309
View abstract

The functional organization of brain networks relies on a delicate balance between segregation and integration, which supports both localized neural processing and global information exchange. While numerous whole-brain imaging studies have linked disruptions in this balanced topology to Major Depressive Disorder (MDD), it remains unclear whether such macroscale alterations are reflected in neuronal circuit dynamics at the cellular level. In this study, we investigated whether neuronal networks derived from human induced pluripotent stem cells (hiPSCs) of nine MDD patients display a distinct functional topology compared to nine matched controls. We obtained skin biopsies from all participants, cultivated fibroblasts, and reprogrammed these into hiPSCs. We then differentiated hiPSCs into neural progenitor cells (NPCs), which we later developed into neurons. We recorded spontaneous activity in the derived neuronal networks using calcium imaging, and applied graph theory analysis to quantify differences in functional topology between groups. We observed a significant decrease in the clustering coefficient and average node degree in MDD-derived neural networks. Furthermore, global efficiency showed a downward trend across varying thresholds and network sizes in patient-derived lines. Together, these findings demonstrate diminished segregation and reduced overall nodal connectivity in MDD-derived neural networks. This suggests that a predisposition for less efficient functional topology exists in depression at the microscale, highlighting the utility of hiPSC technology in modeling cellular disease mechanisms and exploring potential cellular correlates of network-level phenomena reported in depression.

NeuroImage 2026 Oct 24 PubMed
19 Serum metabolic characteristics and potential biomarkers of first-episode schizophrenia: An exploratory machine learning-based metabolomics study. Peng XQ et al. 10.1016/j.pnpbp.2026.111984
View abstract

Metabolomics studies in first-episode schizophrenia (FES) remain limited and heterogeneous. This study aimed to characterize the serum metabolomic profile of FES, identify metabolic biomarkers, and develop machine learning-based predictive models. In this exploratory study, serum metabolomic profiles were compared among healthy controls (HCs; n = 10), untreated FES patients (n = 10), and the same patients after second-generation antipsychotics (SGAs) treatment. Candidate biomarkers were evaluated using six machine learning algorithms. Bayesian network analysis and weighted gene co-expression network analysis (WGCNA) were further applied to explore the network relationships. Cross-dataset integrative analysis was additionally performed using an external public dataset comprising patients with schizophrenia (n = 30) and HCs (n = 30). Disease-associated candidate biomarkers included PG(16:0/18:1), PC(20:4/15:0), PC(22:5/15:0), PG(18:1/18:1), and PE(16:0/16:0), whereas treatment-associated biomarkers included PG(16:0/18:1), PC(20:4/15:0), PC(22:5/15:0), cholesterol sulfate, DG(20:4/22:4), and Phe-Thr-Asn-Lys. All selected candidate biomarkers achieved Area Under the Curve (AUC) values above 0.9, with performance varying across algorithms. In the Bayesian networks, disease served as a direct parent node of the Montreal Cognitive Assessment (MoCA) score and all biomarkers, whereas treatment shared direct edges with the Positive and Negative Syndrome Scale (PANSS) score and all biomarkers except cholesterol sulfate, which was indirectly connected via Phe-Thr-Asn-Lys. WGCNA identified metabolite modules significantly associated with disease status (r = -0.88, p < 0.01) and treatment (r = 0.75, p < 0.01). Cross-dataset analysis identified phenylpyruvic acid, SM(d18:1/22:1(13Z)), and 2-octenoylcarnitine as shared differential metabolites with modest-to-moderate discrimination. These exploratory findings reveal potential serum metabolic signatures of FES and provide a basis for the development of objective biomarkers for diagnosis and SGAs treatment monitoring, warranting validation in larger independent cohorts.

Progress in neuro-psychopharmacology & biological psychiatry 2026 Oct 24 PubMed
20 Comparison of Locomotor Depression and Spontaneous Pain-Related Behaviors Induced by Colon and Bladder Visceral Pain Models in Mice. Negus SS et al. 10.1016/j.jpain.2026.106479
View abstract

Visceral pain is a prevalent class of pain states that can depress normal behavior and reduce quality of life. Behavioral recovery is a goal of treatment, but pharmacotherapy is challenging, and refinement of preclinical visceral-pain endpoints could facilitate evaluation of novel candidate analgesics. Accordingly, the goal of the present study was to evaluate expression and treatment of pain-related locomotor depression in mouse models of visceral pain. Intracolonic 2,4,6-trinitrobenzenesulfonic acid (TNBS) and intraperitoneal cyclophosphamide (CYP) modeled colon and bladder pain, respectively, and these organ-targeted models were compared to intraperitoneal lactic acid (IP acid) as another more extensively evaluated visceral-pain model. Locomotion by male and female ICR mice was assessed in chambers with two compartments separated by a wire-mesh barrier that could be surmounted to cross between compartments. Primary dependent measures were vertical locomotion between compartments (Crosses) and horizontal locomotion represented by the sum of photobeam breaks within each compartment (Movement). Hunched posture and facial grimace were assessed as supplemental pain behaviors, and sensitivity of pain-related behaviors to the nonsteroidal anti-inflammatory drug ketoprofen and opioid agonist morphine were also examined. IP acid, TNBS, and CYP all produced depression of Crosses and Movement along with stimulation of hunched posture and grimace, although CYP effects were weaker than those of IP acid and TNBS. We have shown previously that IP acid effects can be blocked by ketoprofen and morphine, but both drugs were less effective against TNBS and CYP. The procedure described here could aid future efforts to discover improved pharmacotherapies for visceral pain. PERSPECTIVE: Visceral pain can depress normal behavior, and behavioral recovery is a treatment goal. This article compared locomotor depression produced by three visceral pain models in mice. All models depressed locomotion, but colon- and bladder-pain models were resistant to conventional analgesics. This procedure could aid development of improved visceral-pain pharmacotherapies.

The journal of pain 2026 Oct 24 PubMed
21 Psychocognitive vulnerability and risk of incident ADL disability and mortality across six prospective cohort studies. Zeng Y et al. 10.1016/j.jad.2026.122666
View abstract

INTRODUCTION: Depressive symptoms and lower word-recall performance often co-occur with chronic disease in middle-aged and older adults. We examined their separate and joint associations with subsequent activities of daily living (ADL) disability and mortality across multimorbidity strata. METHODS: We pooled harmonised data from CHARLS, ELSA, HRS, KLoSA, MHAS and SHARE. Adults ≥45 years contributed observed person-intervals. Study-wave standardised scores defined none, single-domain or dual-domain vulnerability. Outcomes were incident ADL disability (primary) and all-cause mortality. Modified Poisson models estimated risk ratios (RRs); cohort-stratified Cox models estimated hazard ratios (HRs). RESULTS: Among 257,922 participants (mean age 62.4 years; 55.5% female), 181,551 contributed 512,522 eligible ADL intervals (45,430 events). Complete-case adjusted analyses included 179,248 participants (500,911 intervals; 44,178 ADL events) and 213,268 participants (605,704 mortality windows; 27,782 deaths). ADL RRs versus none were 1.68 (95% CI, 1.65-1.71) for single-domain and 2.19 (2.12-2.27) for dual-domain vulnerability, with 48.7 and 85.3 excess events per 1000 standardised interval observations, respectively. Corresponding summary mortality HRs were 1.56 (95% CI, 1.51-1.60) and 1.79 (1.71-1.86). Interaction-model absolute ADL risk was 27.2% with dual-domain vulnerability and ≥ 3 chronic conditions at the next observed assessment. Four categories distinguished endpoint-specific single-domain associations; joint ADL associations were below multiplicative and additive expectations (interaction ratio 0.756; relative excess risk due to interaction [RERI] -0.240). Mortality hazards were nonproportional. DISCUSSION: A simple psychocognitive vulnerability classification was associated with graded risks of ADL disability and mortality across six cohorts. The largest absolute ADL risk increases accompanied multimorbidity.

Journal of affective disorders 2026 Oct 24 PubMed
22 Targeting neuroinflammation in neuropsychiatric disorders: The role of NLRP3 inflammasome signalling. Fernandez Lopez M et al. 10.1016/j.euroneuro.2026.113897 European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2026 Oct 24 PubMed
23 The mediating effect of circulating C-reactive protein on the association between depression and brain cortical dysconnectivity. Shahi S et al. 10.1016/j.pscychresns.2026.112357
View abstract

Chronic low grade systemic inflammation is associated in the pathophysiology of major depressive disorder (MDD). However, the specific cortical structural connectivity changes associated with peripheral inflammation in MDD remains poorly understood. In this case-control study, 113 MDD patients and 107 healthy controls underwent 3T MRI and measurement of high sensitivity C-reactive protein (CRP). Fiber connectivity density (FiCD) mapping, a data driven whole-cortex pipeline combining cortical surface reconstruction with diffusion tractography, was used to examine depression and CRP interaction effects on cortical connectivity. A subgroup of MDD patients completed a six-week antidepressant follow-up with repeat MRI. A significant interaction between depression and CRP was identified in the left rostral middle frontal cortex (LRMF). FiCD in the LRMF was significantly lower in MDD patients than controls and negatively correlated with CRP in patients but not controls. Following six weeks of antidepressant treatment, FiCD in LRMF increased significantly, and this increase was negatively correlated with baseline. Peripheral inflammation is possibly associated with disrupted cortical connectivity in MDD and disturbs the brain structural recovery process during antidepressant treatment. The left rostral middle frontal cortex possibly serves as an important target.

Psychiatry research. Neuroimaging 2026 Oct 21 PubMed
24 Reduced short-lag autoregressive carry-over in resting-state latent dynamics in major depressive disorder. Yamaki N et al. 10.1016/j.pscychresns.2026.112359
View abstract

Major depressive disorder (MDD) is increasingly characterized as a disorder of brain dynamics, but the temporal scale on which resting-state activity differs from healthy controls remains unclear. We analyzed resting-state fMRI data from 71 participants (51 MDD, 20 controls; OpenNeuro ds002748) using bilateral grid-extracted left-right difference signals projected into a control-defined latent space. Across 30 analysis configurations spanning five denoising pipelines, three latent dimensionalities, and two left-right correction settings, MDD showed reduced mean lag-1 autocorrelation in 24 of 30 configurations (integrated β = -0.0321, p = 0.036) and reduced AR(1) gain φ in 24 of 30 (β = -0.0316, p = 0.037), both robust to adjustment for pipeline, age, sex, and head motion. The broader autocorrelation area under lags 1-10 was not significantly reduced (β = -0.0099, p = 0.22), and lag-by-lag analysis localized the group difference specifically to lag 1. A model-comparison analysis identified AR-gain reduction as one of three competing candidate generative transformations rather than the unique winner. MDD is thus associated with a focal short-lag autoregressive carry-over reduction, a candidate latent-dynamical phenotype rather than a fully identified mechanism.

Psychiatry research. Neuroimaging 2026 Oct 22 PubMed
25 Association of complete blood count derived indices of inflammation with psychiatric disorders and mortality. Rozema L et al. 10.1016/j.genhosppsych.2026.10.003
View abstract

OBJECTIVE: Psychiatric disorders have been implicated in a bidirectional association with inflammation. Current methods of measuring inflammation in observational data are limited. Complete blood count (CBC)-derived indices of inflammation may address this limitation, though gaps in knowledge on their association with psychiatric disorders and mortality in the presence of these disorders remain. We sought to determine if six psychiatric diagnostic groups - substance, trauma, depressive, psychotic, personality, and bipolar - were associated with increased inflammatory indices, and if presence of these groups moderated the indices' effect on mortality. METHODS: We identified annualized values of six CBC-derived indices of inflammation - systemic immune response index (SIRI), systemic immune inflammation index (SII), aggregate index of systemic inflammation (AISI), monocyte-to-lymphocyte ratio (MLR), neutrophil-to- lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) - in a national cohort of Veterans Affairs healthcare users. To assess the effect of psychiatric disorders on indices, we fit linear mixed effects models on indices with the primary exposure being prior-year psychiatric diagnoses. To assess the effect of inflammatory indices on mortality, we fit Cox proportional hazards models on all-cause mortality and suicide with the primary exposure being a patients' initial inflammatory index. RESULTS: All disorders, save trauma, were associated with higher index values, with the greatest effect being for substance disorders (SIRI: 20.71% [99.17% CI: 20.27, 21.15]). All six indices were associated with increased all-cause mortality and suicide. Only all-cause mortality was moderated by presence of psychiatric disorders. CONCLUSION: In the context of limited generalizability, CBC-derived indices of inflammation serve as readily available measures of inflammation that are associated with psychiatric morbidity and mortality.

General hospital psychiatry 2026 Oct 21 PubMed
DoctiPlus Health Insights are compiled weekly from public trial registries, FDA databases, and academic publishers. All figures reflect the seven-day window ending on the report date. Data is provisional and subject to registry updates.

Primary sources

  • ClinicalTrials.gov — public registry
  • openFDA — adverse events & recalls
  • PubMed / NCBI — research papers
  • Semantic Scholar — citations & papers

About this report

  • Category: Mental Health & Depression
  • Week: October 19 – October 26, 2026
  • Drugs tracked: New Trials This Week, Recruiting Now, Countries
  • Generated: November 16, 2026 at 6:47 AM
© 2026 DoctiPlus Care Vol. 7 · No. 47 · November 16, 2026 — 30 —